Skip to Content

Drug Interactions between coccidioidin skin test and dexchlorpheniramine / methscopolamine / phenylephrine

This report displays the potential drug interactions for the following 2 drugs:

  • coccidioidin skin test
  • dexchlorpheniramine/methscopolamine/phenylephrine

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

phenylephrine methscopolamine

Applies to: dexchlorpheniramine / methscopolamine / phenylephrine and dexchlorpheniramine / methscopolamine / phenylephrine

Methscopolamine may increase the effects of phenylephrine on your blood pressure and heart rate. Before receiving these medications, you should let your doctor know if you have high blood pressure or heart disease. You may not be able to use one or both of these medications, or you may need closer monitoring by your doctor in order to use these medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Moderate

dexchlorpheniramine methscopolamine

Applies to: dexchlorpheniramine / methscopolamine / phenylephrine and dexchlorpheniramine / methscopolamine / phenylephrine

Using dexchlorpheniramine together with methscopolamine may increase side effects such as drowsiness, blurred vision, dry mouth, heat intolerance, flushing, decreased sweating, difficulty urinating, abdominal cramping, constipation, irregular heartbeat, confusion, and memory problems. Side effects may be more likely to occur in the elderly or those with a debilitating condition. You should avoid or limit the use of alcohol while being treated with these medications. Also avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medications affect you. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Moderate

dexchlorpheniramine coccidioidin skin test

Applies to: dexchlorpheniramine / methscopolamine / phenylephrine and coccidioidin skin test

Dexchlorpheniramine may interfere with your response to coccidioidin skin test. If you are currently using or have recently used dexchlorpheniramine, let your doctor know before you get tested with coccidioidin skin test. It is generally best to discontinue dexchlorpheniramine for 2 to 4 days before testing, but you should check with your doctor. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Drug and food interactions

Moderate

dexchlorpheniramine food

Applies to: dexchlorpheniramine / methscopolamine / phenylephrine

Alcohol can increase the nervous system side effects of dexchlorpheniramine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with dexchlorpheniramine. Do not use more than the recommended dose of dexchlorpheniramine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide